Senior R&D exec Sue Dillon jumps ship at J&J, launches mystery biotech startup Aro with Centyrins tech
Two former executive heavyweights at Johnson & Johnson have left the pharma giant to launch a rather stealthy startup called Aro Biotherapeutics – and they …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
